Anthropic Spends $400M to Acquire Biotech AI Startup: Claude Formally Enters Drug Discovery

Sun, 05 Apr 2026 00:00:00 +0000

AI giants are starting to acquire biotech companies. On April 3, it emerged that Anthropic used approximately $400M in stock to acquire a stealth-mode AI biotech startup called Coefficient Bio.

The news spread beyond tech circles into biotech as well.

What Was Acquired

Coefficient Bio is not an ordinary startup. Founders Samuel Stanton and Nathan C. Frey both came from Genentech’s Presptive Design team — one of the world’s top computational drug design labs. They left eight months ago with a clear mission: use AI to accelerate drug discovery.

Life Sciences on AI Brief | AI-101.tech

Anthropic Spends $400M to Acquire Biotech AI Startup: Claude Formally Enters Drug Discovery

What Was Acquired